Nuclear Medicine and Neurooncology (NMN)
LightNews LightNews
banner
nmnsymposium.bsky.social
Nuclear Medicine and Neurooncology (NMN)
@nmnsymposium.bsky.social
170 followers 130 following 110 posts
Advancing Nuclear Medicine and Neurooncology through research and education. Join the #NMN2025 Symposium on May 09/10th 2025 in Vienna, Austria.
nmn-society.org
Posts Replies Media Videos
nmnsymposium.bsky.social
🎧 Check out the The Lancet Oncology podcast discussing the back-to-back publications of the TUXEDO-3 trial: www.thelancet.com/doi/story/10...

👉 Cohort 1 (breast cancer) paper:
authors.elsevier.com/a/1m007_XRRT...

👉Cohort 2 (lung cancer) paper: authors.elsevier.com/a/1m0075EIIg...
October 28, 2025 at 8:19 AM
nmnsymposium.bsky.social
☢️ Insightful perspective article by William Chen and David Raleigh on the LUMEN-1 trial in The Journal of Nuclear Medicine :
jnm.snmjournals.org/content/earl...
@eortc.org
October 19, 2025 at 9:44 AM
nmnsymposium.bsky.social
🔥 Check out the brand new editorial featuring the two randomized sister trials from Europe and the US on theranostics for meningioma in the Journal of Nuclear Medicine: jnm.snmjournals.org/content/earl...
@eortc.org
October 18, 2025 at 4:04 PM
nmnsymposium.bsky.social
🧠 💫 Amino acid PET imaging and its potential role for supramarginal resection being discussed at #EANO2025.
@eanoassociation.bsky.social
October 18, 2025 at 12:53 PM
nmnsymposium.bsky.social
🤩 Emeline Tabouret presenting the randomized phase II LUMEN-1 (EORTC-2334-BTG) trial on Lu-DOTATATE in recurrent meningioma at #EANO2025 - 🚀 accrual going very well!
@eortc.org @eanoassociation.bsky.social
October 18, 2025 at 7:07 AM
nmnsymposium.bsky.social
🌍 Strengthening medical imaging capacity will save lives: spotlight on the recent @who.int landmark resolution on strengthening medical imaging capacity worldwide.
www.nature.com/articles/s41...
@natureportfolio.nature.com
October 14, 2025 at 10:13 AM
nmnsymposium.bsky.social
🤩 🤝 Looking forward to welcoming the Editor-in-Chief of The Lancet Oncology David Collingridge at #NMN2026: www.nmn-society.org!
@thelancetoncol.bsky.social
www.thelancet.com/journals/lan...
October 14, 2025 at 9:29 AM
nmnsymposium.bsky.social
🤩 Proud to announce that COGNO is endorsing the #NMN2026 Symposium to be held on May 07/08th 2026 in Vienna: www.nmn-society.org! 🌍 Looking forward to collaborating with our colleagues from Australia on molecular imaging and theranostics for brain tumors! 💫
cogno.org.au
@nathaliealbert.bsky.social
October 10, 2025 at 2:27 PM
nmnsymposium.bsky.social
💫 Check out the new article in the inaugural issue of the new EANM Journal:
EANM insights on PET-based response assessment in neuro-oncology: things are moving forward!
doi.org/10.1016/j.ea...
@eanm.org
September 24, 2025 at 7:09 AM
nmnsymposium.bsky.social
🚨 💫 Happy to share that that @eortc.org is a 🙌 collaboration partner for the #NMN2026 Symposium: www.nmn-society.org!
@nathaliealbert.bsky.social
September 13, 2025 at 2:08 PM
nmnsymposium.bsky.social
🤩 Happy to share that the EANO is endorsing the #NMN2026 Symposium: www.nmn-society.org! 💫 Excited to join forces with the leading mulitdisciplinary neuro-oncology society in Europe 🌎 !
www.eano.eu
@eanoassociation.bsky.social @nathaliealbert.bsky.social @michael-platten.bsky.social
September 1, 2025 at 10:18 AM
nmnsymposium.bsky.social
🔥 Hot off the press in Neuro-Oncology by @mj-mair.bsky.social et al: Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET – a retrospective, bicentric cohort study.
academic.oup.com/neuro-oncolo...

@eanoassociation.bsky.social
August 26, 2025 at 12:35 PM
nmnsymposium.bsky.social
🤩 Happy to share that the Asian Society for Neuro-Oncology (ASNO) is endorsing the #NMN2026 Symposium: www.nmn-society.org! 🌎 Looking forward to this collaboration to advance Nuclear Medicine and Neuro-Oncology on a global level!
www.a-sno.org

@nathaliealbert.bsky.social
August 18, 2025 at 11:09 AM
nmnsymposium.bsky.social
🔥 Hot off the press in JNM: [177Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial. 🩺 Study enrollment is ongoing.
jnm.snmjournals.org/content/earl...
@nathaliealbert.bsky.social @journalofnucmed.bsky.social @eortc.org
August 8, 2025 at 8:17 AM
nmnsymposium.bsky.social
🗓️ ✏️ Mark your calendar for #NMN2026! 💫 We have chosen another fantastic venue in Vienna for the next edition of the "Nuclear Medicine Meets Neuro-Oncology" Symposium to be held on May 07/08th 2026 in Vienna! 🌎
www.nmn-society.org

@nathaliealbert.bsky.social @eanoassociation.bsky.social @eortc.org
July 18, 2025 at 11:08 AM
nmnsymposium.bsky.social
🌍 Today is #glioblastomaday. 🤝 Everyday Nuclear Medicine and Neuro-Oncology are jointly working to improve diagnosis and therapy for patients with glioblastoma through research and education. 💫
July 16, 2025 at 7:20 AM
nmnsymposium.bsky.social
🤩 Online now: check out the fotos and impressions 📸 from #NMN2025 - where Nuclear Medicine and Neuro-Oncology met to advance molecular imaging and theranostics for patients with brain tumors! 🚀
www.nmn-society.org/past-events/
July 11, 2025 at 7:51 AM
nmnsymposium.bsky.social
🚨 Apply now for the NMN Clinical tRiaLisT Fellowship and learn how to make an impact through clinical trials on theranostics for brain tumors! 🧠 www.nmn-society.org/clinical-tri...

@nathaliealbert.bsky.social
June 11, 2025 at 11:32 AM
nmnsymposium.bsky.social
💫 🌍 Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey.
link.springer.com/article/10.1...
@mj-mair.bsky.social @nathaliealbert.bsky.social @eortc.org @eanoassociation.bsky.social
June 4, 2025 at 2:40 PM
nmnsymposium.bsky.social
🥁 Breaking News Editorial on the TUXEDO-3 trial published in Neuro-Onology.
academic.oup.com/neuro-oncolo...
@neuroonc.bsky.social
June 4, 2025 at 7:06 AM
nmnsymposium.bsky.social
🌍 🤝 207 participants from 24 countries around the world joined the #NMN2025 Symposium and made it a very special event with stimulating presentations and inspiring interactions on molecular imaging and theranostics of CNS tumors! 🤩 📝 Mark your calendars for #NMN2026 on May 07/08 2026 in Vienna!
May 23, 2025 at 3:20 PM
nmnsymposium.bsky.social
🥳 Today, the first patient was successfully randomized in the international LUMEN-1 trial, the first prospective randomized study to evaluate the efficacy of [177Lu]Lu-DOTATATE in recurrent meningioma!
www.eortc.org/research_fie...
@nathaliealbert.bsky.social @eortc.org
May 15, 2025 at 3:32 PM
nmnsymposium.bsky.social
🧠 🤩 🌍 Thank you to the stellar faculty of #NMN2025 for helping us put together a symposium full of highlights and inspiration to advance diagnosis and treatment of brain tumors with molecular imaging and theranostics!
May 11, 2025 at 10:44 AM
nmnsymposium.bsky.social
🤩 The stage is set for day 2 of #NMN2025! Getting ready for another day full of cutting edge science on molecular imaging and theranostics of gliomas, brain metastases and meningioms. 🧠
www.nmn-society.org/program/
May 10, 2025 at 6:01 AM
nmnsymposium.bsky.social
🥁 Breaking News Editorial in Neuro-Oncology on PET RANO BM 1.0 criteria for amino acid PET of brain metastases: academic.oup.com/neuro-oncolo....

PET RANO BM 1.0 in Nature Medicine: www.nature.com/articles/s41...

@nathaliealbert.bsky.social @neuroonc.bsky.social @eanoassociation.bsky.social
May 8, 2025 at 2:41 PM